De Novo DNA

De Novo DNA is a private, early-revenue company founded in 2018, offering a sophisticated computational platform for the rational design of genetic systems. Its core technology consists of predictive calculators (e.g., Promoter Calculator, RBS Calculator) that allow users to model and engineer biological parts for precise control of gene expression, serving a large academic and industrial research community. The company leverages its platform to provide both software-as-a-service and custom protein library construction, positioning itself at the intersection of bioinformatics, genetic engineering, and automation in the rapidly growing synthetic biology market.

A web-based suite of predictive biophysical models (Promoter Calculator, RBS Calculator, RBS Library Calculator, Operon Calculator) for designing and optimizing genetic systems to control transcription, translation, and protein expression levels. Complemented by a service for constructing massively parallel protein libraries.

De Novo DNA competes in the biological design software space with companies like Benchling (which offers broader lab data management with some design tools), TeselaGen, and GenoCAD. Its deep focus on predictive biophysical modeling for prokaryotes is a key differentiator, but it may face pressure from platforms incorporating more machine learning or offering broader organism support.